Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the COL11A2 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
The documentation for autosomal dominant nonsyndromic hearing loss 13 is limited primarily due to the rarity of the condition, which affects fewer than 1 in 10,000 individuals. This rarity has resulted in fewer systematic clinical studies and a lack of comprehensive phenotype characterization. Additionally, the genetic basis was only recently identified, leading to ongoing efforts to better understand the clinical features associated with this condition.
To navigate your journey with autosomal dominant nonsyndromic hearing loss 13, consider consulting an audiologist with experience in genetic hearing loss. They can provide tailored assessments and management strategies. Additionally, genetic counseling may be beneficial for understanding the implications of the COL11A2 mutation for you and your family. While there are no specific patient organizations identified for this condition, resources like GARD (rarediseases.info.nih.gov) can offer valuable information and support.
Currently, there is one active clinical trial related to autosomal dominant nonsyndromic hearing loss 13. This trial may explore potential interventions or management strategies for individuals affected by this condition. For more information on this trial, you can visit ClinicalTrials.gov at https://clinicaltrials.gov/search?cond=autosomal%20dominant%20nonsyndromic%20hearing%20loss%2013.
Actionable guidance for navigating care for autosomal dominant nonsyndromic hearing loss 13
To navigate your journey with autosomal dominant nonsyndromic hearing loss 13, consider consulting an audiologist with experience in genetic hearing loss. They can provide tailored assessments and management strategies. Additionally, genetic counseling may be beneficial for understanding the implications of the COL11A2 mutation for you and your family. While there are no specific patient organizations identified for this condition, resources like GARD (rarediseases.info.nih.gov) can offer valuable information and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Age of onset indicates when symptoms typically first appear.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.